Despite its emerging significance, the relationship between NUSAP1 and critical processes in cancer immunology and oncology, such as molecular mechanisms of immune regulation, immunotherapeutic responsiveness, and drug sensitivity, remains largely unexplored in gliomas. This evidence concerns the gene NUSAP1 and central nervous system cancer.